NDC 43093-105

Fanatrex

Gabapentin

Fanatrex is a Oral Kit in the Human Prescription Drug category. It is labeled and distributed by California Pharmaceuticals Llc. The primary component is .

Product ID43093-105_24ea29f7-9f22-1bed-e054-00144ff8d46c
NDC43093-105
Product TypeHuman Prescription Drug
Proprietary NameFanatrex
Generic NameGabapentin
Dosage FormKit
Route of AdministrationORAL
Marketing Start Date2010-05-15
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameCalifornia Pharmaceuticals LLC
Active Ingredient Strength0
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 43093-105-01

1 KIT in 1 KIT (43093-105-01) * 10.5 g in 1 BOTTLE, GLASS * 420 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2010-05-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43093-105-01 [43093010501]

Fanatrex KIT
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-05-15
Inactivation Date2020-01-31

Drug Details

OpenFDA Data

SPL SET ID:8c3ce84f-336b-4e8e-9593-81baec57ec46
Manufacturer

NDC Crossover Matching brand name "Fanatrex" or generic name "Gabapentin"

NDCBrand NameGeneric Name
70332-105FanatrexFanatrex
43093-105FanatrexFanatrex
0093-4443GabapentinGabapentin
0093-4444GabapentinGabapentin
0143-3991GabapentinGabapentin
0143-3993GabapentinGabapentin
0143-3994GabapentinGabapentin
0143-9992GabapentinGabapentin
0143-9993GabapentinGabapentin
0143-9994GabapentinGabapentin
0071-0401Neurontingabapentin
0071-0513Neurontingabapentin
0071-0803Neurontingabapentin
0071-0805Neurontingabapentin
0071-0806Neurontingabapentin
0071-2012Neurontingabapentin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.